WOBURN, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ:REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, today announced that members from the Replimune management team will present and host investor meetings at the following three conferences:
Leerink Partners 2024 Global Biopharma Conference
Date: Tuesday, March 12, 2024
Fireside Chat Time: 2:20 pm EDT
Jefferies Biotech on the Bay Miami Summit
Date: Wednesday, March 13, 2024
Barclays 26th Annual Global Healthcare Conference